Literature DB >> 22405456

[Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].

C Carra-Dalliere1, E Thouvenot, A Bonafé, F Ducray, J Touchon, M Charif.   

Abstract

INTRODUCTION: Cerebellar ataxia and stiff person-syndrome are the main neurological syndromes associated with antibodies to glutamic acid decarboxylase (GAD). CASE REPORT: A 59-year-old patient, with history of polymyalgia rheumatica and active smoking, was admitted for subacute cerebellar ataxia and memory dysfunction explained by limbic encephalitis on brain MRI. He also presented with orthostatic hypotension and erectile dysfunction revealing autonomic dysfunction. CSF was inflammatory and antibodies to GAD were positive. Onconeuronal antibodies including GABA(B) receptor antibodies were negative. Patient's condition quickly improved after intravenous immunoglobulins. A few months later, a small cell lung carcinoma was diagnosed and precociously treated.
CONCLUSION: This case report underlines the importance of appropriate studies to confirm a primitive neoplasia, when confronted with limbic encephalitis and cerebellar ataxia, even if anti-GAD antibodies rarely define paraneoplastic syndromes.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405456     DOI: 10.1016/j.neurol.2011.07.018

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Paraneoplastic neurological syndromes: general treatment overview.

Authors:  Aurélien Viaccoz; Jérôme Honnorat
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

2.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Authors:  Helena Ariño; Romana Höftberger; Nuria Gresa-Arribas; Eugenia Martínez-Hernández; Thaís Armangue; Michael C Kruer; Javier Arpa; Julio Domingo; Bojan Rojc; Luis Bataller; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

Review 3.  Anti-glutamic acid decarboxylase antibody positive neurological syndromes.

Authors:  Hassaan Tohid
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.